Precedence Research, Recently Published Report on “Medical Device Outsourcing Market Size, Share, Growth, Trends, Segment Forecasts, Regional Outlook 2020 - 2027”. The report offers an up-to-date analysis regarding the current market scenario, latest trends, key drivers, potential challenges, profitability graph and the overall market environment.
The global Medical Device Outsourcing Market value is projected to reach US Dollar 231 billion by 2027 and is projected to expand at a CAGR of ~9.98%% from 2020 to 2027.
Global medical device industry is under persistent pressure to control expenses without compromising research development, protection and timeline. New technologies, process progressions and elderly population have led explosive growth within the market since past few years. With its development, guidelines progress and become more severe and difficult and competition more extreme. Medical device original equipment manufacturers (OEMs) with the help of outsourcing some of the tasks, can take benefit of lowered operation prices, augmented agility, a decline in time-to-market and a improvement on their return of investment (ROI). In turn, OEMs can renovate their businesses into tactical investments reasonably than simply cost centers. Contract manufacturers have positively profited from this growth of the medical device sector. Nevertheless, growth of the outsourced medical manufacturing sector is outpacing that of the device industry as a whole, demonstrating a trend near the augmented practice of outsourcing.
Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1057
Growth Factors
Continuously, rising occurrence of chronic ailments is one of the foremost factors subsidizing to the growth of medical device outsourcing market. Regulatory bodies are mostly concentrating on the quality of the healthcare devices delivered to the public. Therefore this is inspiring numerous companies in the market to bid numerous services such as regulatory consulting. For instance, the European Medical Device Regulation commences special impulsive inspection of outsourced products to test the quality along with conformity with standards.
The vital influencer of medical device outsourcing market is the profitable and swift manufacturing of products. Manufacturers subcontract the production of their goods to decrease time and cost. Furthermore, as a replacement for fetching in equipment to manufacture medical devices, it is desirable for the producers to subcontract the production operations completely to contract manufacturing organizations (CMOs) based in China, Taiwan, and South Korea, and numerous other nations in order to competently handle maintenance and quality.
Report Highlights
- In 2019, contract manufacturing garnered majority of share in service segment on account of growing trend of outsourcing, particularly in emergent countries
- In 2019, Asia Pacific lead medical device outsourcing market with prominent revenue share. High demands for new-fangled technologies plus developing healthcare infrastructure are likely to expedite the governance of this region in medical device outsourcing marketplace during the estimate period
- The quality assurance segment is projected to observe the utmost CAGR over the estimate period
- North America is estimated to observe the firmest growth throughout the estimate period due to growing occurrence of chronic illnesses in this region
Buy this Premium Research Report, Click here@ https://www.precedenceresearch.com/checkout/1057
Regional Snapshots
In 2019, North America emerged as one of the major markets for medical device outsourcing services. This growth is on account of existence of great number of medical device companies, and easy accessibility of high-end medical devices in the region.
Asia Pacific medical device outsourcing market is anticipated to exhibit the firmest growth in demand and is foreseen to propagate at a strong CAGR throughout the estimate period. This growth is credited to low cost of labor and relatively less costly infrastructure price than other established economies across the globe. Tremendous growth in the Asia Pacific region is also augmented by the existence of a enormous patient pool undergoing from chronic disorders and upsurge in the requirement for reasonable medical devices.
Multiple significant participants in the medical device outsourcing market are anticipated to observe abundant growth prospects in established countries. The numerous international medical device establishments select to manufacture their devices in emergent nations of Asia Pacific because of small labor costs and great quality. For example, labor cost is quite less in India, Vietnam, and Indonesia in comparison with other countries. However, China has observed noteworthy increase in labor cost in the latest few years. Numerous Asian nations produce medical device products including rubber gloves, drainage bags and surgical tapes in great number, on account of less overhead for utilities, cheap raw materials, equipment, rent, and medical device components. In addition, companies there also create sophisticated Class III medical devices, like drug-eluting stents.
Browse Related Studies:
- Medical Imaging Outsourcing Market - The global market size was valued at US$ 7.24 Billion in 2019 and expected to reach US$ 10.61 Billion by 2027, with at a compound annual growth rate (CAGR) of 4.9% during the forecast period 2020 to 2027.
- Medical Affairs Outsourcing Market - The global market size was valued at US$ 1.43 billion in 2019 and predicted to register a compound annual growth rate (CAGR) of around 10.75% during period 2020 to 2027.
- Medical Billing Outsourcing Market - The global market size was valued at USD 9.5 billion in 2019 and expected to reach USD 23.7 billion by 2027 and poised to grow at a compound annual growth rate (CAGR) 12.1% during the forecast period 2020 to 2027.
Key Players & Strategies
Some of the foremost companies functioning in the global medical device outsourcing market comprise Integer Heraeus Holding GmbH, Holdings Corporation, Onex Corporation, Cardinal Health, Inc., Flex Ltd., Plexus Corp., West Pharmaceutical Services, Inc., TE Connectivity Ltd., and Sanmina Corporation. These key companies are concentrating on industry expansions and procurements to capture a greater market share. For illustration, TE Connectivity Ltd, a major participant in connectivity and sensors, acquired Creganna Medical in April 2016. Creganna Medical manufactures and designs minimally invasive delivery and access devices serving medical device original equipment manufacturers (OEMs).
Market Segmentation
By Service
- Product Upgrade Services
- Regulatory Affairs Services
- Quality Assurance
- Product Maintenance Services
- Product Testing & Sterilization Services
- Product Design and Development Services
- Product Implementation Services
- Contract Manufacturing
By Application
- Drug delivery
- Dental
- Diabetes care
- Cardiology
- Endoscopy
- IVD
- Ophthalmic
- Diagnostic imaging
- Orthopedic
- General and plastic surgery
- Others
By Regional
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Medical Device Outsourcing Market, By Service
7.1. Medical Device Outsourcing Market, by Service Type, 2020-2027
7.1.1. Product Upgrade Services
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Regulatory Affairs Services
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Quality Assurance
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Product Maintenance Services
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Product Testing & Sterilization Services
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Product Design and Development Services
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Product Implementation Services
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. Contract Manufacturing
7.1.8.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Medical Device Outsourcing Market, By Application
8.1. Medical Device Outsourcing Market, by Application, 2020-2027
8.1.1. Drug Delivery
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Dental
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Diabetes care
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Cardiology
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Endoscopy
8.1.5.1. Market Revenue and Forecast (2016-2027)
8.1.6. IVD
8.1.6.1. Market Revenue and Forecast (2016-2027)
8.1.7. Ophthalmic
8.1.7.1. Market Revenue and Forecast (2016-2027)
8.1.8. Diagnostic imaging
8.1.8.1. Market Revenue and Forecast (2016-2027)
8.1.9. Orthopedic
8.1.9.1. Market Revenue and Forecast (2016-2027)
8.1.10. General and plastic surgery
8.1.10.1. Market Revenue and Forecast (2016-2027)
8.1.11. Others
8.1.11.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Medical Device Outsourcing Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Service (2016-2027)
9.1.2. Market Revenue and Forecast, by Application (2016-2027)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Service (2016-2027)
9.1.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Service (2016-2027)
9.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Service (2016-2027)
9.2.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Service (2016-2027)
9.2.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Service (2016-2027)
9.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Service (2016-2027)
9.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Service (2016-2027)
9.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Service (2016-2027)
9.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Service (2016-2027)
9.3.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Service (2016-2027)
9.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Service (2016-2027)
9.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Service (2016-2027)
9.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Service (2016-2027)
9.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Service (2016-2027)
9.4.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Service (2016-2027)
9.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Service (2016-2027)
9.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Service (2016-2027)
9.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Service (2016-2027)
9.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Service (2016-2027)
9.5.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Service (2016-2027)
9.5.4.2. Market Revenue and Forecast, by Application (2016-2027)
Chapter 10. Company Profiles
10.1. Intertek Group PLC
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. TüvSüd AG
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Wuxi Apptec
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. SGS SA
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Toxikon, INC.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Eurofins Scientific
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. American Preclinical Services
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Sterigenics International LLC
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Pace Analytical Services LLC.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. North American Science Associates, Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Charles River Laboratories International, Inc.
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1057
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 774 402 6168
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
0 Comments